JAMIE NICOLE HANNAH

Allopathic & Osteopathic Physicians|Family Medicine COLUMBUS, IN NPI 1790778785

General Payments — all program years on this page

$1,076.00

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 66
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $207.72 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $207.7212

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $83.594
Novo Nordisk AS $61.514
Astellas Pharma US Inc $21.211
Merck Sharp & Dohme Corporation $14.201
Lilly USA, LLC $13.791
Acerta Pharma LLC $13.421

By program year

Program yearAmountRecords
2020 $279.9619
2021 $26.082
2022 $162.7510
2023 $399.4923
2024 $207.7212

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096611652 Novo Nordisk Inc $14.62 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096813572 Novo Nordisk Inc $16.01 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096971702 Novo Nordisk Inc $14.23 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097219445 Novo Nordisk Inc $16.65 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103875164 ABBVIE INC. $25.67 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103875166 ABBVIE INC. $14.25 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103875168 ABBVIE INC. $21.68 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103875170 ABBVIE INC. $21.99 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104210575 AstraZeneca Pharmaceuticals LP $13.42 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135043536 Lilly USA, LLC $13.79 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139280410 Astellas Pharma US Inc $21.21 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141632317 Merck Sharp & Dohme LLC $14.20 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.